Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 41.21
-3.75 (-8.34%)
At close: Jun 2, 2026
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 5.74 billion as of June 2, 2026. Its market cap has increased by 22.00% in one year.
Market Cap
5.74B
Enterprise Value
4.10B
Revenue
453.39M
Ranking
n/a
PE Ratio
139.69
Stock Price
41.21
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 5.74B, a decrease of -44.98%. That is a compound annual growth rate of -14.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 6.26B | 12.27% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 6.63B |
| Suzhou Fengbei Biotech Stock | 6.29B |
| Chengdu Kanghua Biological Products | 6.12B |
| Jiangsu Aidea Pharmaceutical Group | 6.06B |
| Wuhan Keqian Biology Co.,Ltd | 6.06B |
| Novogene | 5.87B |
| Shenzhen Weiguang Biological Products | 5.67B |
| Hangzhou Biotest Biotech | 5.63B |